Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Risk of Bleeding With Dabigatran in Atrial Fibrillation,”1 published in 2015, there were several errors in the presentations of the 95% CIs in Figure 2 and Figure 3. This article was corrected online.
Errors in Figures. JAMA Intern Med. 2018;178(12):1732. doi:10.1001/jamainternmed.2018.5747
Best of JAMA Network 2022